On Wednesday shares of zulily, Inc. (NASDAQ:ZU) closed at $10.82. Company’s EPS growth for next 5 years is recorded as 38.50%. zulily, Inc. (NASDAQ:ZU) is struggling to convince investors that it isn’t just a flash in the pan. On Tuesday, Zulily lowered its 2015 sales forecast after reporting $306.6 million in revenue for the first three months of the year. That was up 29% from a year earlier, a sharply slower growth rate than it posted just three months earlier, when sales increased 52%.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) in last trading activity advanced 0.97% to close at $470.01. Company weekly performance is 0.07% while its quarterly performance stands at 17.10%. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is -5.14% away from its 52 week high. Regeneron Pharmaceuticals (NASDAQ:REGN) had its price target increased by Leerink Swann from $527.00 to $559.00 in a research report sent to investors on Wednesday morning.
On Wednesday shares of Primerica, Inc. (NYSE:PRI) closed at $46.30. Company’s sales growth for last 5 years was -9.60% and EPS growth for next 5 years is recorded as 10.00%. Primerica Inc (NYSE:PRI), a provider of life insurance and investment products, on Wednesday reported first-quarter net earnings of $43.4 million or $0.82 per share compared with $45 million or $0.81 per share last year.
Pampa Energia SA (NYSE:PAM) has institutional ownership stands at 21.80%. In last trading activity company’s stock closed at $16.78. Pampa Energia S.A. (NYSE:PAM), announces that it hold a General Ordinary Shareholders’ Meeting on first and second call, on April 30, 2015, at 11:00 a.m. and 12:00 p.m., respectively, at the registered office, located at Ortiz de Ocampo 3302, Building 4, Ground Floor, City of Buenos Aires
On last trading day Orthofix International N.V. (NASDAQ:OFIX) moved down -0.71% to close at $31.98. Its volatility for the week is 4.99% while volatility for the month is 2.73%. OFIX’s sales growth for past 5 years was -5.20% and its EPS growth for past 5 years was 40.80%. Orthofix International N.V. (NASDAQ:OFIX) monthly performance is -14.03%. On Apr 29, Orthofix International N.V. (NASDAQ:OFIX) reported its financial results for the fourth quarter and fiscal year ended December 31, 2014 and announced the appointment of Doug Rice as the Company’s new Chief Financial Officer, effective April 24, 2015. Net sales were $100.3 million, a decrease of 5.3% on a reported basis (3.4% on a constant currency basis). Gross profit was $78.8 million, or 78.6% of net sales, compared to $71.8 million, or 67.8% of net sales, in 2013.